Plasma TNF-α levels are higher in early pregnancy in patients with secondary compared with primary recurrent miscarriage

American Journal of Reproductive Immunology

Volumn 70, Issue 5, 2013, Pages 347-358

  Piosik, Zofia Maria ^a   Goegebeur, Yuri ^b   Klitkou, Louise ^c   Steffensen, Rudi ^c   Christiansen, Ole Bjarne ^a,c  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Primary recurrent miscarriage; Secondary recurrent miscarriage; Tumour necrosis factor alpha dynamics; Tumour necrosis factor alpha promoter polymorphism

Indexed keywords

CHORIONIC GONADOTROPIN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; RECURRENT ABORTION; STILLBIRTH;

PRIMARY RECURRENT MISCARRIAGE; SECONDARY RECURRENT MISCARRIAGE; TUMOUR NECROSIS FACTOR ALPHA DYNAMICS; TUMOUR NECROSIS FACTOR ALPHA PROMOTER POLYMORPHISM;

ABORTION, HABITUAL; ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GRAVIDITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84885476419     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12135     Document Type: Article

References (42)

1. Rai R, Regan L: Recurrent miscarriage. Lancet 2006; 368:601-611.
2. Christiansen OB, Nielsen HS, Kolte AM: Inflammation and miscarriage. Semin Fetal Neonatal Med 2006; 5:302-308.
3. Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995; 273:1933-1936.
4. Choudhury SR, Knapp LA: Human reproductive failure I. Immunological factors. Hum Reprod Update 2000; 7:113-134.
5. Haider S, Knöfler M: Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 2009; 30:111-123.
6. Murphy SP, Fast LD, Hanna NN, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005; 175:4084-4090.
7. Müller-Eckhardt G, Mallmann P, Neppert J, Lattermann A, Melk A, Heine O, Pfeiffer R, Zingsem J, Domke N, Mohr-Pennert A: Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortion. German RSA/IVIG study group. J Reprod Immunol 1994; 27:95-109.
8. Kruse C, Varming K, Christiansen OB: Prospective, serial investigations of in-vitro lymphocyte production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod 2003; 18:2465-2472.
9. Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S: Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012; 27:349-357.
10. Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS: Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss? Hum Reprod 2002; 17:2439-2444.
11. Christiansen OB, Pedersen B, Rosgaard A, Husth M: A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002; 17:809-816.
12. Christiansen OB, Christiansen BS, Husth M, Mathiesen O, Lauritsen JG, Grunnet N: Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertil Steril 1992; 58:328-334.
13. Heesen M, Kunz D, Wessiepe M, van derPollT, Zwinderman AH, Blomeke B: Rapid genotyping for tumor necrosis factor-alpha (TNF-alpha) -863C/A promoter polymorphism that determines TNF-alpha response. Clin Chem 2004; 50:226-228.
14. R Development Core Team (2010). R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing. ISBN 3-900051-07-0, URL http://www.R-project.org/.
15. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Fostegård J, Wiman B, Prince JA, de Faire U: Association of TNF-α serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006; 187:408-414.
16. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
17. Sacks GP, Studena K, Sargent IL, Redman CW: Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179:80-86.
18. Bell KA, van Deerlin PG, Haddad BR, Feinberg RF: Cytogenetic diagnosis of "normal 46, XX" karyotypes in spontaneous abortions may be misleading. Fertil Steril 1999; 71:334-341.
19. Kuliev A, Zlatopolsky Z, Kirillova I, Spivakova J, Janzen JC: Meiosis errors in over 20, 000 oocytes studied in the practice of preimplantation aneuploidy testing. Reprod Biomed Online 2011; 22:2-8.
20. Ogasawara M, Aoki K, Okada S, Suzumori K: Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 89:300-304.
21. Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerillo M, Coulam CB: Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65:250-253.
22. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-357.
23. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N: A brief review of recent data on some cytokine expressions at the meterno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53:241-256.
24. Wang WJ, Hao CF, Yi-Lin, Yin GJ, Bao SH, Qiu LH, Lin QD: Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 2010; 84:164-170.
25. Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee S-K, Beaman K: Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertil Steril 2008; 89:157-165.
26. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli GF, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4:1020-1024.
27. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L: Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16:2219-2226.
28. Lee SK, Kim JY, Hur SE, Kim CJ, Na BJ, Lee M, Gilman-Sachs A, Kwak-Kim J: An imbalance in interleukin-17-producing T and Foxp3 regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod 2011; 26:2964-2971.
29. Kronborg CS, Gjedsted J, Vittinghus E, Hansen TK, Allen J, Knudsen UB: Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011; 90:791-796.
30. Calleja-Agius J, Jauniaux E, Muttukrishna S: Placental villous expression of TNF-α and IL-10 and effect of oxygen tension in euploid early pregnancy failure. Am J Reprod Immunol 2012; 67:515-525.
31. Christiansen OB: A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 1996; 2:271-293.
32. Christiansen OB, Steffensen R, Nielsen HS: The impact of anti-HY responses in current and subsequent pregnancies of patients with recurrent pregnancy losses. J Reprod Immunol 2010; 85:9-14.
33. Nielsen HS, Steffensen R, Lund M, Egestad L, Mortensen LH, Andersen AM, Lidegaard Ø, Christiansen OB: Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum Reprod 2010; 25:1543-1552.
34. Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, Holers VM, Robinson WH: Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 2012; 7:e35296.
35. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
36. Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C: Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 2011; 22:88-102.
37. Grutters JC, Sato H, Pantelidis P, Lagan AL, McGrath DS, Lammers JW, van den Bosch JM, Wells AU, du Bois RM, Welsh KI: Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165:1119-1124.
38. Li H, Groop L, Nilsson A, Weng J, Tuomi T: A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor α promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J Clin Endocrinol Metab 2003; 88:2767-2774.
39. Finan RR, Al-Irhayim Z, Mustafa FE, Al-Zaman I, Mohammed FA, Al-Khateeb GM, Madan S, Issa AA, Almawi WY: Tumor necrosis factor-α polymorphisms in women with idiopathic recurrent miscarriage. J Reprod Immunol 2010; 84:186-192.
40. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, Claas F: The presence of HLA antibodies in recurrent miscarriage patients is associated with a reduced chance of live birth. J Reprod Immunol 2010; 87:67-73.
41. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M: Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2006; 114:134-142.
42. Winger E, Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60:8-16.